Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03367819 |
| Title | Isatuximab in Combination With REGN2810 in Patients With Advanced Malignancies |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Sanofi |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ITA | GBR | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Investigational Site Number 8400003 | Birmingham | Alabama | 35249 | United States | Details | |
| Investigational Site Number 8400007 | Atlanta | Georgia | 30322 | United States | Details | |
| Investigational Site Number 8400002 | Hackensack | New Jersey | 07601 | United States | Details | |
| Investigational Site Number 8400005 | Nashville | Tennessee | 37203 | United States | Details | |
| Investigational Site Number 8400004 | Houston | Texas | 77030 | United States | Details | |
| Investigational Site Number 2500002 | Bordeaux Cedex | 33076 | France | Details | ||
| Investigational Site Number 2500001 | Villejuif | 94800 | France | Details | ||
| Investigational Site Number 3800003 | Rozzano | Milano | 20089 | Italy | Details | |
| Investigational Site Number 3800001 | Orbassano | Torino | 10043 | Italy | Details | |
| Investigational Site Number 3800006 | Napoli | 80131 | Italy | Details | ||
| Investigational Site Number 3800004 | Padova | 35128 | Italy | Details | ||
| Investigational Site Number 3800005 | Verona | 37134 | Italy | Details | ||
| Investigational Site Number 1580002 | Tainan | 704 | Taiwan | Details | ||
| Investigational Site Number 1580001 | Taipei 100 | Taiwan | Details | |||
| Investigational Site Number 8260001 | Sutton | Surrey | SM2 5PT | United Kingdom | Details | |
| Investigational Site Number 8260002 | Newcastle upon Tyne | NE7 7DN | United Kingdom | Details |